Table 2.

Representative microRNA expression in patients with multiple sclerosis^a

MicroRNA	Relative level	Log fold change
miR‐140‐5p	−27·008 ± 2·98	−2·99 ± 0·44
miR‐30a‐3p	−24·533 ± 2·88	−3·106 ± 0·49
miR‐660‐5p	−21·140 ± 2·83	−2·394 ± 0·38
miR‐30c‐5p	−21·013 ± 2·82	−2·077 ± 0·33
miR‐223‐3p	−13·153 ± 2·41	−4·983 ± 0·51
miR‐92a‐3p	−12·491 ± 2·38	−1·650 ± 0·18
miR‐26a‐5p	−11·673 ± 2·35	−2·558 ± 0·35
miR‐181a‐5p	18·773 ± 2·62	2·048 ± 0·32
let‐7e	17·587 ± 2·58	2·13 ± 0·17
miR‐455‐3p	14·457 ± 2·48	2·819 ± 0·41
miR‐423‐5p	4·536 ± 0·52	1·531 ± 0·18
mir‐15	4·485 ± 0·51	1·547 ± 0·22
miR‐140‐3p	3·078 ± 0·48	1·462 ± 0·19

^aThe relative expression level and fold change for the part of the significantly changed microRNAs in peripheral blood mononuclear cells of patients with remitting multiple sclerosis compared with the controls. The full list of microRNAs and the detailed information of the microRNA array can be found in the ArrayExpress database under accession number E‐MTAB‐3437. The data were expressed as mean ± SEM from four patients with multiple sclerosis and four controls.